FDA WARNING_LETTER - GSM Services, LLC - May 30, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
On May 17, 2023, the FDA issued Warning Letter 7533 to GSM Services, LLC., a domestic importer of pipe tobacco, cigars, and roll-your-own tobacco products. The FDA determined that GSM Services, LLC. failed to pay user fees assessed under section 919 of the FD&C Act (21 U.S.C. § 387s). Specifically, the company has outstanding user fee payments for multiple fiscal quarters from 2019 through 2022, with assessment invoice dates ranging from March 1, 2019, to December 1, 2022.
As a result of the failure to pay assessed user fees, all regulated tobacco products imported by GSM Services, LLC. are deemed adulterated under section 902(4) of the FD&C Act (21 U.S.C. § 387b(4)). The introduction or delivery into interstate commerce of adulterated tobacco products is a prohibited act under section 301(a) of the FD&C Act (21 U.S.C. § 331(a)). Furthermore, the FDA will be unable to issue substantial equivalence orders for new tobacco products until all assessed fees are paid in their entirety, even if a repayment plan is established.
GSM Services, LLC. is required to submit a written response within
ID · f07f5a1b-4847-4b77-a44e-cbe9dc06fe40
Full citation text and observation details available on the Dashboard.